IDEXX Laboratories, Inc. (ETR:IX1)

IDEXX Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	208.17	288.27	453.93	112.55	144.45	383.93
Cash & Short-Term Investments	208.17	288.27	453.93	112.55	144.45	383.93
Cash Growth	-32.55%	-36.50%	303.33%	-22.09%	-62.38%	325.05%
Accounts Receivable	638.83	534.33	512.56	442.47	406.12	355.27
Other Receivables	76.13	26.99	16.97	48.43	19.46	19.48
Receivables	714.97	561.32	529.53	490.9	425.58	374.74
Inventory	391.56	381.88	380.28	367.82	269.03	209.87
Prepaid Expenses	60.82	58.63	48.37	41.74	42	34.56
Other Current Assets	101.54	109.81	83.14	88.46	74.59	59.64
Total Current Assets	1,477	1,400	1,495	1,101	955.66	1,063
Property, Plant & Equipment	867.64	829.25	817.68	768.09	692.77	646.34
Long-Term Investments	31.76	31	30.25	30.25	5.25	-
Goodwill	413.65	405.1	365.96	361.8	359.35	243.35
Other Intangible Assets	114.79	111.68	84.5	97.67	99.04	52.54
Long-Term Accounts Receivable	216.78	185.51	167.96	148.97	122.16	91.68
Long-Term Deferred Tax Assets	31.5	125.63	107.36	55.22	24.78	31.55
Long-Term Deferred Charges	-	-	-	-	122.41	116.09
Other Long-Term Assets	233.54	205.38	190.96	183.29	55.8	50.28
Total Assets	3,387	3,293	3,260	2,747	2,437	2,295
Accounts Payable	122.27	114.21	110.64	110.22	116.14	74.56
Accrued Expenses	373.01	418.33	372.36	364.69	395.77	342.87
Short-Term Debt	455	250	250	579	73.5	-
Current Portion of Long-Term Debt	150	167.79	75	74.98	75	49.99
Current Portion of Leases	26.65	21.54	19.8	20.43	19.93	17.73
Current Income Taxes Payable	89.2	62.25	86.55	48.55	42.61	42.68
Current Unearned Revenue	35.69	33.8	37.2	37.94	40.03	42.57
Other Current Liabilities	-	-	-	-	0.6	12.37
Total Current Liabilities	1,252	1,068	951.55	1,236	763.58	582.76
Long-Term Debt	374.83	449.79	622.88	694.39	775.21	858.49
Long-Term Leases	106.49	97.84	99.67	101.24	87.38	77.04
Long-Term Unearned Revenue	31.05	26.94	28.53	30.86	41.17	46.16
Long-Term Deferred Tax Liabilities	3.72	11.31	7.24	8.15	8.94	11.71
Other Long-Term Liabilities	57.62	44.34	65.53	67.59	70.94	85.6
Total Liabilities	1,826	1,698	1,775	2,138	1,747	1,662
Common Stock	10.83	10.78	10.75	10.72	10.69	10.65
Additional Paid-In Capital	1,793	1,674	1,570	1,463	1,377	1,295
Retained Earnings	6,144	5,332	4,445	3,600	2,920	2,176
Treasury Stock	-6,319	-5,334	-4,475	-4,392	-3,571	-2,800
Comprehensive Income & Other	-66.72	-87.76	-65.68	-72.61	-47.77	-49.11
Total Common Equity	1,561	1,595	1,485	608.74	689.99	632.09
Minority Interest	-	-	-	-	-	0.71
Shareholders' Equity	1,561	1,595	1,485	608.74	689.99	632.8
Total Liabilities & Equity	3,387	3,293	3,260	2,747	2,437	2,295
Total Debt	1,113	986.95	1,067	1,470	1,031	1,003
Net Cash (Debt)	-904.8	-698.68	-613.42	-1,357	-886.56	-619.32
Net Cash Per Share	-11.10	-8.39	-7.30	-16.05	-10.24	-7.14
Filing Date Shares Outstanding	79.85	81.33	83.09	82.9	84.25	85.43
Total Common Shares Outstanding	80	81.6	83.03	82.89	84.56	85.45
Working Capital	225.24	331.98	543.71	-134.33	192.08	479.98
Book Value Per Share	19.52	19.55	17.88	7.34	8.16	7.40
Tangible Book Value	1,033	1,079	1,034	149.27	231.61	336.2
Tangible Book Value Per Share	12.91	13.22	12.45	1.80	2.74	3.93
Land	-	23.99	22.4	22.22	22.64	13.98
Buildings	-	446.16	432.04	356.05	329.09	319.38
Machinery	-	891	837.15	772.56	728.74	686.49
Construction In Progress	-	67.14	79.06	97.31	62.34	39.76
Leasehold Improvements	-	119.84	116.35	107.25	93.25	82.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.